These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
89 related items for PubMed ID: 15937403
1. Cytoprotective effect of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) against ischemia/reperfusion-induced injury in rat heart involves inhibition of fodrin breakdown and protein tyrosine nitration. Hashimoto M, Takada Y, Takeuchi Y, Kasahara J, Hisa H, Shirasaki Y, Fukunaga K. J Pharmacol Sci; 2005 Jun; 98(2):142-50. PubMed ID: 15937403 [Abstract] [Full Text] [Related]
2. DY-9760e, a novel calmodulin inhibitor, exhibits cardioprotective effects in the ischemic heart. Fukunaga K, Han F, Shioda N, Moriguchi S, Kasahara J, Shirasaki Y. Cardiovasc Drug Rev; 2006 Jun; 24(2):88-100. PubMed ID: 16961723 [Abstract] [Full Text] [Related]
3. Inhibition of dystrophin breakdown and endothelial nitric-oxide synthase uncoupling accounts for cytoprotection by 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e) in left ventricular hypertrophied Mice. Han F, Lu YM, Hasegawa H, Kanai H, Hachimura E, Shirasaki Y, Fukunaga K. J Pharmacol Exp Ther; 2010 Feb; 332(2):421-8. PubMed ID: 19889795 [Abstract] [Full Text] [Related]
8. The post-ischemic administration of 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel calmodulin antagonist, prevents delayed neuronal death in gerbil hippocampus. Hashiguchi A, Yano S, Morioka M, Hamada J, Shirasaki Y, Kochi M, Fukunaga K. J Pharmacol Sci; 2004 Sep; 96(1):65-72. PubMed ID: 15359085 [Abstract] [Full Text] [Related]
9. Post-ischemic administration of DY-9760e, a novel calmodulin antagonist, reduced infarct volume in the permanent focal ischemia model of spontaneously hypertensive rat. Takagi K, Sato T, Shirasaki Y, Narita K, Tamura A, Sano K. Neurol Res; 2001 Sep; 23(6):662-8. PubMed ID: 11547940 [Abstract] [Full Text] [Related]
10. Inhibition of neuronal nitric oxide synthase activity by 3-[2-[4-(3-chloro-2-methylphenyl)- 1-piperazinyl]ethyl]-5, 6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate (DY-9760e), a novel neuroprotective agent, in vitro and in cultured neuroblastoma cells in situ. Fukunaga K, Ohmitsu M, Miyamoto E, Sato T, Sugimura M, Uchida T, Shirasaki Y. Biochem Pharmacol; 2000 Sep 01; 60(5):693-9. PubMed ID: 10927028 [Abstract] [Full Text] [Related]
11. DY-9760e, a calmodulin antagonist, reduces brain damage after permanent focal cerebral ischemia in cats. Sugimura M, Takamori H, Fukushi H, Kitano Y, Kanazawa Y, Shirasaki Y. Biol Pharm Bull; 2005 Apr 01; 28(4):629-33. PubMed ID: 15802800 [Abstract] [Full Text] [Related]
14. DY-9760e, a novel calmodulin antagonist, reduces infarction after permanent focal cerebral ischemia in rats. Sato T, Takamori H, Shirasaki Y. Pharmacology; 2004 May 01; 71(1):38-45. PubMed ID: 15051921 [Abstract] [Full Text] [Related]
15. Determination of a novel calmodulin antagonist, 3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1- (4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate, DY-9760e, in human plasma using solid-phase extraction and high-performance liquid chromatography with fluorescence detection. Tachibana S, Fukano A, Sudo K, Tanaka M. J Chromatogr B Biomed Sci Appl; 1999 Oct 29; 734(1):39-45. PubMed ID: 10574188 [Abstract] [Full Text] [Related]
17. Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys. Tachibana S, Fujimaki Y, Tachibana M, Tanaka M, Kurata T, Okazaki O, Sudo K. Arzneimittelforschung; 2005 Oct 29; 55(3):135-44. PubMed ID: 15819385 [Abstract] [Full Text] [Related]